Skip to main content
Premium Trial:

Request an Annual Quote

Dollars for Disease


Just how much money is allotted to study a certain disease — and which gets more, liver cancer or liver disease? (The answer is liver disease.) Earlier this year, the National Institutes of Health updated its tally of how much funding goes into research for a range of diseases and conditions each year. For 2006, these figures are based on grants, contracts, and ongoing research at the NIH. The numbers for 2007 and 2008 are estimates, using current funding levels, this year’s current rate level, and the budget for 2008 as a guide.

From the NIH’s list of research areas, Genome Technology picked out a sampling of diseases. Overall, most categories such as multiple sclerosis and epilepsy will see a slight decline of a million or two dollars over the next couple of years. Influenza research, though, will continue to receive more and more attention, as will diabetes studies. The big winner, in terms of getting the most funding, is HIV/AIDS research.

To see a PDF of this data, click here.

File Attachments
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.